Keyphrases
Multiple Myeloma
100%
Minimal Residual Disease
100%
Myeloma Cells
100%
Circulating Tumor Cells
100%
CD138
100%
Multiple Myeloma Patients
40%
Low Expression
20%
Bone Marrow
20%
Bortezomib
20%
Drug Exposure
20%
Syndecan-1
20%
Peripheral Blood
20%
Prognostic Marker
20%
Hypoxia
20%
Multidrug-resistant
20%
Surface Markers
20%
Drug Combination
20%
New Markers
20%
In Vitro-in Vivo
20%
Medicine and Dentistry
Multiple Myeloma
100%
Minimal Residual Disease
100%
Circulating Tumor Cell
100%
Myeloma Cell
55%
Biological Marker
11%
In Vitro
11%
Hypoxia
11%
Bortezomib
11%
Drug Exposure
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Multiple Myeloma
100%
Minimal Residual Disease
100%
Biological Marker
11%
Bortezomib
11%
Hypoxia
11%
Myeloma
11%
Neuroscience
In Vivo
100%
In Vitro
100%
Bortezomib
100%
Immunology and Microbiology
Multiple Myeloma
100%
Circulating Tumor Cell
100%
Myeloma Cell
55%
Drug Exposure
11%
Biochemistry, Genetics and Molecular Biology